ESKIMO 3 250 CAPS

Omega 3 are polyunsaturated components of plant-based and animal-based foodstuffs, and their absorption via the west is extremely important. The fact that they are present in all cell membranes means that their presence in the organism has an effect on all biological processes. Inuïtes, waarvan gekend is dat ze veel vis eten die rijk is aan omega 3, vertonen niet alleen weinig cardiovasculaire aandoeningen, maar ook weinig huidziekten. At the same time, it can be assumed that this is due to the omega 3 enzymes which have a strong biochemical and physical effect on the membranes. Omega 3 oil makes oil softer and more elastic through different mechanisms such as the ones that can be screwed into the soepel with the help of water. Zonder deze vetzuren zouden het lichaam en de huid van de vissen heel stram zijn. As a result, health problems such as oiliness, eczema and psoriasis may be altered by the name of omega-3 with the name of their ontstekingswerende eigenschappen (1, 2, 3, 4). Cardiovasculair stelsel Omega 3 hebben verschillende effecten: 1. Duidelijke verlaging van triglyceridengehalte (25% vermindering van de triglyceriden voor 3 g omega 3) als natuurlijke ligand van de alfa-PPARs (5) 2. Stijging van HDL (5) 3. Verbetering van de endotheelfunctie namelijk dankzij hun ontstekingswerende eigenschappen (5) 4. Antiaggregerende eigenschappen van de bloedplaatjes (5) 5. Verbetering van variaties in hartritme (5) 6. Daling van mortaliteit bij hartinsufficiëntie (5) 7. Daling van risico op ventriculaire fibrillatie tijdens reperfusie na hartinfarct (5) 8. Verbetering van systolische en diastolische bloeddruk (5

2 tot 3 capsules per day or as required. Tijdens de maaltijden.

Gluten-vrij Geschikt bij zwangerschap Geschikt bij borstvoeding Lactose-vrij

2 tot 3 capsules per day or as needed. Tijdens de maaltijden.

1. Alm B, Aberg N, Erdes L, Möllborg P, Pettersson R, Norvenius SG, Goksör E, Wennergren G. Early introduction of fish decreases the risk of eczema in
   infants. Arch Dis Child. 2009 Jan;94(1):11-5.

2. Koch C, Dölle S, Metzger M, Rasche C, Jungclas H, Rühl R, Renz H, Worm M.
   Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized,
   double-blind, controlled trial. Br J Dermatol. 2008 Apr;158(4):786-92.

3. Zulfakar MH, Edwards M, Heard CM. Is there a role for topically delivered
   eicosapentaenoic acid in the treatment of psoriasis? Eur J Dermatol. 2007
   Jul-Aug;17(4):284-91.

4. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J
   Am Coll Nutr. 2002 Dec;21(6):495-505.

5. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for
   cardioprotection 83(6):730>. Mayo Clin Proc. 2008;83(3):324-332

6. BLOCK RC, HARRIS WS, REID KJ, SANDS SA, SPERTUS JA: EPA and DHA in blood cell
   membranes from acute coronary syndrome patients and controls. Atherosclerosis
   197: 821-828, 2008.

7. Schuchardt JP, Huss M, Stauss-Grabo M, Hahn A. Significance of long-chain
   polyunsaturated fatty acids (PUFAs) for the development and behaviour of
   children. Eur J Pediatr. 2010 Feb;169(2):149-64.

8. Gow RV, Matsudaira T, Taylor E, Rubia K, Crawford M, Ghebremeskel K,
   Ibrahimovic A, Vallée-Tourangeau F, Williams LM, Sumich A. Total red blood
   cell concentrations of omega-3 fatty acids are associated with emotion-
   elicited neural activity in adolescent boys with attention-deficit
   hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-
   Mar;80(2-3):151-6.

9. Sumich A, Matsudaira T, Gow RV, Ibrahimovic A, Ghebremeskel K, Crawford M,
   Taylor E. Resting state electroencephalographic correlates with red cell
   long-chain fatty acids, memory performance and age in adolescent boys with
   attention deficit hyperactivity disorder. Neuropharmacology. 2009 Dec;57(7-
   8):708-14.

10. Bélanger SA, Vanasse M, Spahis S, Sylvestre MP, Lippé S, L'heureux F,
    Ghadirian P, Vanasse CM, Levy E. Omega-3 fatty acid treatment of children
    with attention-deficit hyperactivity disorder: A randomized, double-blind,
    placebo-controlled study. Paediatr Child Health. 2009 Feb;14(2):89-98.

11. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of
    childhood depression: a controlled, double-blind pilot study. Am J
    Psychiatry. 2006 Jun;163(6):1098-100.

12. McNamara RK. DHA deficiency and prefrontal cortex neuropathology in recurrent
    affective disorders. J Nutr. 2010 Apr;140(4):864-8.

13. Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis
    of the effects of n-3 long-chain polyunsaturated fatty acids on depressed
    mood. Am J Clin Nutr. 2010 Mar;91(3):757-70.

14. Freeman MP. Omega-3 fatty acids in major depressive disorder J Clin
    Psychiatry. 2009;70 Suppl 5:7-11

15. Borja-Hart NL, Marino J. Role of omega-3 Fatty acids for prevention or
    treatment of perinatal depression. Pharmacotherapy. 2010 Feb;30(2):210-6.

16. Féart C, Peuchant E, Letenneur L, Samieri C, Montagnier D, Fourrier-Reglat A,
    Barberger-Gateau P. Plasma eicosapentaenoic acid is inversely associated
    with severity of depressive symptomatology in the elderly: data from the
    Bordeaux
    sample of the Three-City Study. Am J Clin Nutr. 2008 May;87(5):1156-62.

17. Serini S, Piccioni E, Calviello G. Dietary n-3 PUFA vascular targeting and
    the prevention of tumor growth and age-related macular degeneration. Curr Med
    Chem. 2009;16(34):4511-26.

18. Sangiovanni JP, Agrón E, Meleth AD, Reed GF, Sperduto RD, Clemons TE, Chew
    EY; Age-Related Eye Disease Study Research Group {omega}-3 Long-chain
    polyunsaturated fatty acid intake and 12-y incidence of neovascular age-
    related macular degeneration and central geographic atrophy: AREDS report 30,
    a prospective cohort study from the Age-Related Eye Disease Study Am J Clin
    Nutr. 2009 Dec;90(6):1601-7.

19. Ruggiero C, Lattanzio F, Lauretani F, Gasperini B, Andres-Lacueva C,
    Cherubini A. Omega-3 polyunsaturated fatty acids and immune-mediated
    diseases: inflammatory bowel disease and rheumatoid arthritis. Curr Pharm
    Des. 2009;15(36):4135-48.

20. Proudman SM, Cleland LG, James MJ. Dietary omega-3 fats for treatment of
    inflammatory joint disease: efficacy and utility. Rheum Dis Clin North Am.
    2008 May;34(2):469-79.

21. Brunborg LA, Madland TM, Lind RA, Arslan G, Berstad A, Frøyland L. Effects
    of short-term oral administration of dietary marine oils in patients with
    inflammatory bowel disease and joint pain: a pilot study comparing seal oil
    and cod liver oil. Clin Nutr. 2008 Aug;27(4):614-22.

22. Gruenwald J, Petzold E, Busch R, Petzold HP, Graubaum HJ. Effect of
    glucosamine sulfate with or without omega-3 fatty acids in patients with
    osteoarthritis Adv Ther. 2009 Sep;26(9):858-71.

23. Furuhjelm C, Warstedt K, Larsson J, Fredriksson M, Böttcher MF, Fälth-
    Magnusson K, Duchén K. Fish oil supplementation in pregnancy and lactation
    may decrease the risk of infant allergy. Acta Paediatr. 2009 Sep;98(9):1461-

De omega 3-vetzuren hebben een invloed op de bloedplaatjesaggregatie enkunnen dus de bloedingstijd verlengen. Het aanvullen van een tekort aan omega
3-vetzuren is echter wel aangewezen.

NUTRITIONELE INFORMATIE PER 3 CAPSULES
Omega-3 meervoudig onverzadigde vetzuren	500.0 mg
waarin
EPA (eicosapentaeenzuur)	240.0 mg
DHA (docosahexaeenzuur)	160.0 mg
Vitamin E (emulsie van d-alfatocoferol)	4.5 mg	(38% RI*)
Ingrediënten: Visolie van vis uit diepzeewater (triglyceridenvorm), gemengde tocoferolen Hulpstoffen: limoenolie, rozemarijnolie, sojalecithine, ascorbylpalmitaat * RI = Referentie Inname